Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7141)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hartman J, Bichoupan K, Patel N, Chekuri S, Harty A, Dieterich D, Perumalswami P, Branch AD. Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs. World J Gastroenterol 2015; 21(43): 12430-12438 [PMID: 26604650 DOI: 10.3748/wjg.v21.i43.12430] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i43/12430.htm |
| Number | Citing Articles |
| 1 |
Heather L. Stevenson, Netanya S. Utay. Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era. Tropical Diseases, Travel Medicine and Vaccines 2016; 2(1) doi: 10.1186/s40794-016-0038-5
|
| 2 |
Hafsa Aziz, Muneeba Aziz, Muzaffar Lateef Gill. Analysis of Host and Viral-Related Factors Associated to Direct Acting Antiviral Response in Hepatitis C Virus Patients. Viral Immunology 2018; 31(3): 256 doi: 10.1089/vim.2017.0124
|
| 3 |
Xiao-Wei Xu, Xiao-Xin Wu, Ke-Da Chen, Da-Zhi Chen, Hui-Lin Ou, Jun-Wei Su, Hai-Ying Yu, Hang-Ping Yao, Lan-Juan Li. Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China. Medicine 2018; 97(38): e12403 doi: 10.1097/MD.0000000000012403
|
| 4 |
V. Cento, S. Barbaliscia, I. Lenci, T. Ruggiero, C.F. Magni, S. Paolucci, S. Babudieri, M. Siciliano, C. Pasquazzi, A. Ciancio, C.F. Perno, F. Ceccherini-Silberstein, V. Micheli, Y. Troshina, E. Biliotti, M. Milana, M. Melis, E. Teti, L. Lambiase, B. Menzaghi, L.A. Nicolini, S. Marenco, V.C. Di Maio, M. Aragri, A. Pecchioli, A. Bertoli, C. Sarrecchia, M. Macera, N. Coppola, M. Puoti, D. Romagnoli, A. Pellicelli, S. Bonora, S. Novati, F. Baldanti, V. Ghisetti, M. Andreoni, G. Taliani, G. Rizzardini, M. Angelico. Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life. Clinical Microbiology and Infection 2017; 23(10): 777.e1 doi: 10.1016/j.cmi.2017.04.005
|